SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-05-058390
Filing Date
2005-11-30
Accepted
2005-11-30 17:17:27
Documents
1
Group Members
CITADEL CREDIT PRODUCTS LTD.CITADEL DERIVATIVES GROUP LLCCITADEL EQUITY FUND LTD.CITADEL INVESTMENT GROUP, L.L.C.CITADEL KENSINGTON GLOBAL STRATEGIES FUND LTD.CITADEL WELLINGTON LLCKENNETH GRIFFIN

Document Format Files

Seq Description Document Type Size
1 BENEFICIAL OWNERSHIP OF 5% OR MORE a05-21010_1sc13g.htm SC 13G 316404
  Complete submission text file 0001104659-05-058390.txt   318564
Mailing Address 352 KNOTTER DRIVE CHESHIRE CT 06511
Business Address 352 KNOTTER DRIVE CHESHIRE CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Subject) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 0731
Type: SC 13G | Act: 34 | File No.: 005-47771 | Film No.: 051235356
SIC: 2834 Pharmaceutical Preparations

Mailing Address 131 S. DEARBORN STREET, 32ND FLOOR CHICAGO IL 60603
Business Address 131 S. DEARBORN STREET, 32ND FLOOR CHICAGO IL 60606 3123952100
CITADEL L P (Filed by) CIK: 0001027745 (see all company filings)

IRS No.: 364111741 | State of Incorp.: IL | Fiscal Year End: 1231
Type: SC 13G